When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NBRV - FDA accepts Nabriva's NDAs for IV and oral lefamulin; shares up 4% premarket
Nabriva Therapeutics plc
The FDA has accepted Nabriva Therapeutics' (NASDAQ:NBRV) New Drug Applications (NDAs) for both the intravenous (IV) and oral formulations of lefamulin, a semi-synthetic pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia (CABP).
More news on: Nabriva Therapeutics, Healthcare stocks news, Stocks on the move,